Location: Palo Alto, CA
CIK: 0001306923 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $863M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 2,138,963 | $143M | 16.6% | $17.79 | +118.0% | COM PAR $.01 | 457669307 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,130,167 | $93.05M | 10.8% | $83.16 | +0.1% | COM | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 9,029,843 | $89.58M | 10.4% | $9.63 | +6.6% | COM | 03152W109 |
| UTHR | UNITED THERAPEUTICS CORP | 266,914 | $85.03M | 9.9% | $89.23 | +196.6% | COM | 91307C102 |
| BIIB | BIOGEN INC | 289,050 | $67.01M | 7.8% | $264.98 | -18.0% | COM | 09062X103 |
| STAA | STAAR SURGICAL CO | 1,381,619 | $65.78M | 7.6% | $24.23 | +80.8% | COM PAR $0.01 | 852312305 |
| — | ALNYLAM PHARMACEUTICALS INC | 183,123 | $44.5M | 5.2% | $243.00 | — | COM | 02043QAB3 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,418,841 | $39.31M | 4.6% | $28.41 | -43.2% | COM | 004225108 |
| PRTA | PROTHENA CORP PLC | 1,666,378 | $34.39M | 4.0% | $21.46 | +0.9% | SHS | G72800108 |
| SRPT | SAREPTA THERAPEUTICS INC | 201,683 | $31.87M | 3.7% | $111.32 | +15.4% | COM | 803607100 |
| ANAB | ANAPTYSBIO INC | 803,641 | $20.14M | 2.3% | $19.13 | +21.7% | COM | 032724106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 2,116,403 | $16.97M | 2.0% | $5.23 | +104.8% | COM | 462260100 |
| — | REVANCE THERAPEUTICS INC | 5,257,086 | $13.51M | 1.6% | $21.40 | — | COM | 761330109 |
| ALKS | ALKERMES PLC | 495,592 | $11.94M | 1.4% | $22.36 | +9.7% | SHS | G01767105 |
| — | SAGE THERAPEUTICS INC | 1,010,833 | $10.98M | 1.3% | $42.50 | — | COM | 78667J108 |
| EHTH | EHEALTH INC | 2,350,190 | $10.65M | 1.2% | $38.13 | -86.8% | COM | 28238P109 |
| NVCR | NOVOCURE LTD | 561,908 | $9.625M | 1.1% | $58.84 | -70.1% | ORD SHS | G6674U108 |
| ALGN | ALIGN TECHNOLOGY INC | 37,772 | $9.119M | 1.1% | $149.18 | +86.6% | COM | 016255101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 405,193 | $8.319M | 1.0% | $16.84 | +24.3% | COM | 87164F105 |
| — | ACELYRIN INC | 1,715,180 | $7.564M | 0.9% | $6.75 | — | COM | 00445A100 |
| — | NEVRO CORP | 750,371 | $6.318M | 0.7% | $21.87 | — | COM | 64157F103 |
| CYTK | CYTOKINETICS INC | 111,717 | $6.053M | 0.7% | $6.71 | +799.1% | COM NEW | 23282W605 |
| GOSS | GOSSAMER BIO INC | 6,277,093 | $5.655M | 0.7% | $1.58 | -52.6% | COM | 38341P102 |
| — | ELEVATION ONCOLOGY INC | 1,800,106 | $4.86M | 0.6% | $4.52 | — | COM | 28623U101 |
| — | BLUEBIRD BIO INC | 4,633,351 | $4.56M | 0.5% | $1.35 | — | COM | 09609G100 |
| — | KARYOPHARM THERAPEUTICS INC | 5,102,193 | $4.427M | 0.5% | $16.36 | — | COM | 48576U106 |
| — | VERVE THERAPEUTICS INC | 575,817 | $2.81M | 0.3% | $13.94 | — | COM | 92539P101 |
| NUVB | NUVATION BIO INC | 772,652 | $2.256M | 0.3% | $1.92 | +58.9% | COM | 67080N101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $2.212M | 0.3% | $15.56 | +68.5% | COM | 604749101 |
| RLMD | RELMADA THERAPEUTICS INC | 732,400 | $2.197M | 0.3% | $3.27 | +10.6% | COM | 75955J402 |
| TSHA | TAYSHA GENE THERAPIES INC | 811,268 | $1.817M | 0.2% | $2.02 | +43.7% | COM SHS | 877619106 |
| STOK | STOKE THERAPEUTICS INC | 125,861 | $1.7M | 0.2% | $6.06 | +122.9% | COM | 86150R107 |
| HUM | HUMANA INC | 3,985 | $1.489M | 0.2% | $369.63 | -10.7% | COM | 444859102 |
| TVTX | TRAVERE THERAPEUTICS INC | 110,719 | $910K | 0.1% | $23.56 | -71.4% | COM | 89422G107 |
| VYNE | VYNE THERAPEUTICS INC PIPE | 445,434 | $878K | 0.1% | $3.12 | -20.0% | COM | 92941V308 |
| ALDX | ALDEYRA THERAPEUTICS INC | 225,465 | $746K | 0.1% | $5.95 | -34.1% | COM | 01438T106 |
| ACRS | ACLARIS THERAPEUTICS INC | 569,832 | $627K | 0.1% | $1.19 | -1.5% | COM | 00461U105 |
| — | GENERATION BIO CO | 150,475 | $424K | 0.0% | $2.82 | — | COM | 37148K100 |
| URGN | UROGEN PHARMA LTD | 24,500 | $411K | 0.0% | $27.01 | -47.3% | COM | M96088105 |